77 related articles for article (PubMed ID: 26908082)
1. Practical interpretation of CYP2D6 haplotypes: Comparison and integration of automated and expert calling.
Ruaño G; Kocherla M; Graydon JS; Holford TR; Makowski GS; Goethe JW
Clin Chim Acta; 2016 May; 456():7-14. PubMed ID: 26908082
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-calls.
Gaedigk A; Hernandez J; García-Solaesa V; Sánchez S; Isidoro-García M
Pharmacogenomics; 2011 Nov; 12(11):1617-22. PubMed ID: 22044417
[TBL] [Abstract][Full Text] [Related]
3. Nanopore sequencing of the pharmacogene
Liau Y; Maggo S; Miller AL; Pearson JF; Kennedy MA; Cree SL
Pharmacogenomics; 2019 Sep; 20(14):1033-1047. PubMed ID: 31559921
[No Abstract] [Full Text] [Related]
4. Resolving discordant
Hongkaew Y; Wang WY; Gaedigk R; Sukasem C; Gaedigk A
Pharmacogenomics; 2021 Jun; 22(9):529-541. PubMed ID: 33998274
[No Abstract] [Full Text] [Related]
5. Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.
Buermans HP; Vossen RH; Anvar SY; Allard WG; Guchelaar HJ; White SJ; den Dunnen JT; Swen JJ; van der Straaten T
Hum Mutat; 2017 Mar; 38(3):310-316. PubMed ID: 28044414
[TBL] [Abstract][Full Text] [Related]
6. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model.
Lee SB; Wheeler MM; Patterson K; McGee S; Dalton R; Woodahl EL; Gaedigk A; Thummel KE; Nickerson DA
Genet Med; 2019 Feb; 21(2):361-372. PubMed ID: 29875422
[TBL] [Abstract][Full Text] [Related]
7. High-throughput analysis of informative CYP2D6 compound haplotypes.
Fletcher B; Goldstein DB; Bradman AL; Weale ME; Bradman N; Thomas MG
Genomics; 2003 Feb; 81(2):166-74. PubMed ID: 12620394
[TBL] [Abstract][Full Text] [Related]
8. A statistical variant calling approach from pedigree information and local haplotyping with phase informative reads.
Kojima K; Nariai N; Mimori T; Takahashi M; Yamaguchi-Kabata Y; Sato Y; Nagasaki M
Bioinformatics; 2013 Nov; 29(22):2835-43. PubMed ID: 24002111
[TBL] [Abstract][Full Text] [Related]
9. Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.
Chen X; Shen F; Gonzaludo N; Malhotra A; Rogert C; Taft RJ; Bentley DR; Eberle MA
Pharmacogenomics J; 2021 Apr; 21(2):251-261. PubMed ID: 33462347
[TBL] [Abstract][Full Text] [Related]
10. Deciphering ADME genetic data using an automated haplotype approach.
Guo Y; Farmen MW; Jin Y; Lee HY; Penny MA; Hillgren KM; Fossceco SL
Pharmacogenet Genomics; 2014 Jun; 24(6):292-305. PubMed ID: 24797890
[TBL] [Abstract][Full Text] [Related]
11. Copy number variation and gene rearrangements in CYP2D6 genotyping using multiplex ligation-dependent probe amplification in Koreans.
Kim J; Lee SY; Lee KA
Pharmacogenomics; 2012 Jun; 13(8):963-73. PubMed ID: 22676200
[TBL] [Abstract][Full Text] [Related]
12. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Arneth B; Shams M; Hiemke C; Härtter S
Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
[TBL] [Abstract][Full Text] [Related]
13. National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China.
Lin G; Zhang K; Yi L; Han Y; Xie J; Li J
PLoS One; 2016; 11(9):e0162361. PubMed ID: 27603206
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene.
Skierka JM; Walker DL; Peterson SE; O'Kane DJ; Black JL
Pharmacogenomics; 2012 Jun; 13(8):951-4. PubMed ID: 22676198
[TBL] [Abstract][Full Text] [Related]
15. Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3, *4, and *6) within an Iranian population (Mazandaran).
Hashemi-Soteh SM; Sarzare F; Merat F; Salehifar E; Shiran MR
Genet Test Mol Biomarkers; 2011 Nov; 15(11):821-5. PubMed ID: 21631295
[TBL] [Abstract][Full Text] [Related]
16. Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.
Contreras AV; Monge-Cazares T; Alfaro-Ruiz L; Hernandez-Morales S; Miranda-Ortiz H; Carrillo-Sanchez K; Jimenez-Sanchez G; Silva-Zolezzi I
Pharmacogenomics; 2011 May; 12(5):745-56. PubMed ID: 21391885
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
[TBL] [Abstract][Full Text] [Related]
18. A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotype.
Ishiguro A; Kubota T; Sasaki H; Iga T
Clin Chim Acta; 2004 Sep; 347(1-2):217-21. PubMed ID: 15313161
[TBL] [Abstract][Full Text] [Related]
19. Molecular diversity at the CYP2D6 locus in the Mediterranean region.
Fuselli S; Dupanloup I; Frigato E; Cruciani F; Scozzari R; Moral P; Sistonen J; Sajantila A; Barbujani G
Eur J Hum Genet; 2004 Nov; 12(11):916-24. PubMed ID: 15340360
[TBL] [Abstract][Full Text] [Related]
20. Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences.
Lee SB; Wheeler MM; Thummel KE; Nickerson DA
Clin Pharmacol Ther; 2019 Dec; 106(6):1328-1337. PubMed ID: 31206625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
